feed,title,long_url,short_url
Benzinga,Ionis announces third investigational antisense medicine to treat nonalcoholic steatohepatitis (NASH) enters development,https://www.benzinga.com/pressreleases/20/11/n18500883/ionis-announces-third-investigational-antisense-medicine-to-treat-nonalcoholic-steatohepatitis-nas,https://j.mp/3pSxyBj
